| Announce Date | 01/06/2026 |
| EPS Normalized Actual | $0.49 (Beat by $0.08) |
| EPS GAAP Actual | $0.49 (Beat by $0.08) |
| Revenue Actual | $0.343071B |
| Revenue Surprise | Beat by $343.071M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Aug 2028 | 0 | INF | 0 | 0 | 0 |
| Aug 2028 | 2.955 | 6.44 | 2.8672 | 3.0443 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Nov 2025) | 0.04 | 0.04 | 0.343071B | 100% | 343.07M |
| FQ3 2025 (Aug 2025) | 0.11 | 0.11 | 0.337922B | 100% | 337.92M |
| FQ2 2025 (May 2025) | -0.01 | -0.01 | 0.324251B | 100% | 324.25M |
| FQ2 2016 (May 2016) | -0.0325 | -0.0325 | 0.149609B | 100% | 149.61M |
| FQ3 2016 (Aug 2016) | 0 | 0 | 0.146201B | 100% | 146.2M |
| FQ4 2016 (Nov 2016) | -0.0774 | -0.0774 | 0.159344B | 100% | 159.34M |
| FQ1 2017 (Feb 2017) | -0.0564 | -0.0564 | 0.171954B | 100% | 171.95M |
| FQ2 2017 (May 2017) | 0.28 | 0.28 | 0.206974B | 27.72% | 206.97M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Nov 2027) | 0.54 | -- | 0.52899 | 0.55372 | 2 |
| FQ3 2027 (Aug 2027) | 0.79 | -- | 0.7662 | 0.84048 | 3 |
| FQ2 2027 (May 2027) | 0.71 | -- | 0.68861 | 0.75537 | 3 |
| FQ1 2027 (Feb 2027) | 0.61 | -- | 0.59162 | 0.64898 | 3 |
| FQ4 2026 (Nov 2026) | 0.53 | 92.45 | 0.51403 | 0.56387 | 3 |
| FQ3 2026 (Aug 2026) | 0.52667 | 79.11 | 0.5108 | 0.56032 | 3 |
| FQ2 2026 (May 2026) | 0.505 | 101.98 | 0.48979 | 0.53727 | 3 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Nov 2027) | 0.4B | -- | 0.4B | 0.41B | 2 |
| FQ3 2027 (Aug 2027) | 0.44B | -- | 0.43B | 0.46B | 4 |
| FQ2 2027 (May 2027) | 0.43B | -- | 0.42B | 0.45B | 5 |
| FQ1 2027 (Feb 2027) | 0.42B | -- | 0.41B | 0.44B | 6 |
| FQ4 2026 (Nov 2026) | 0.42B | 17.54 | 0.41B | 0.44B | 6 |
| FQ3 2026 (Aug 2026) | 0.39B | 14.29 | 0.39B | 0.41B | 3 |
| FQ2 2026 (May 2026) | 0.38B | 15.43 | 0.37B | 0.4B | 3 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
3
EPS # of Misses
4
EPS # of in-lines
1
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Nov 2025) | 0.04 | 0.04 | 100% | |
| FQ3 2025 (Aug 2025) | 0.11 | 0.11 | 100% | |
| FQ2 2025 (May 2025) | -0.01 | -0.01 | 100% | |
| FQ2 2016 (May 2016) | -0.0325 | -0.0325 | 100% | |
| FQ3 2016 (Aug 2016) | 0 | 0 | NAN% | |
| FQ4 2016 (Nov 2016) | -0.0774 | -0.0774 | 100% | |
| FQ1 2017 (Feb 2017) | -0.0564 | -0.0564 | 100% | |
| FQ2 2017 (May 2017) | 0.28 | 0.28 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Nov 2025) | $0B | $0.34B | $343.07M | 100% |
| FQ3 2025 (Aug 2025) | $0B | $0.34B | $337.92M | 100% |
| FQ2 2025 (May 2025) | $0B | $0.32B | $324.25M | 100% |
| FQ2 2016 (May 2016) | $0B | $0.15B | $149.61M | 100% |
| FQ3 2016 (Aug 2016) | $0B | $0.15B | $146.2M | 100% |
| FQ4 2016 (Nov 2016) | $0B | $0.16B | $159.34M | 100% |
| FQ1 2017 (Feb 2017) | $0B | $0.17B | $171.95M | 100% |
| FQ2 2017 (May 2017) | $0B | $0.21B | $206.97M | 100% |